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1. Introduction 
The lowering of intracellular 3’,5’-AMP by insulin 
has been shown in liver [l] and adipose tissue [2,3], 
both target organs in which the hormone is known to 
counteract a number of cyclic AMP-controlled meta- 
bolic pathways. From metabolic studies concerning 
the antagonism between glucagon and insulin in liver 
[ 1,4] and of lipolytic hormones and insulin in adi- 
pose cells [S, 61 , an interaction at a site controlling 
the formation of cyclic AMP could be inferred. Al- 
though effects upon adenyl cyclase [7] and cyclic 
nucleotide phosphodiesterase [8,9] after treatment 
of intact cells with insulin have been reported, the 
issue has remained controversial [6, lo] , especially 
since direct effects upon adenyl cyclase could not be 
observed [l l-131. 
We have recently reported a direct in vitro inter- 
action between glucagon and insulin on adenyl cyclase 
activity in a particulate preparation from mouse liver 
[ 141. Furthermore, we have shown that NSILA-S, 
a polypeptide with a similar molecular weight as 
insulin which is known to mimic most metabolic effects 
of the hormone [ 151 could also inhibit the glucagon 
effect over a physiologically relevant concentration 
range, but had no effect upon the fluoride-stimulated 
system. Inactivation of the substance by reduction 
and aminoethylation resulted in complete loss of its 
biological activity and at the same time abolished its 
effect upon the adenyl cydase system [ 141. The 
present report presents further findings with the 
mouse liver preparation and demonstrates a similar 
action of insulin upon adenyl cyclase in rat lipocyte 
“ghosts”, a system which has been developed by 
Rodbell [ 161. 
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2. Experimental 
Crude membrane preparations were obtained from 
fresh mouse livers after complete disruption of cells 
with a high-speed mechanical homogenizer. The assay 
and properties of adenyl cyclase activity in this sys- 
tem have been described [ 171. Minor modi~cations 
include the use of creatin phosphate and creatin phos- 
phokinase for ATP regeneration and the use of 5 mM 
3’,5’-AMP as a trapping system [ 18) in order to pre- 
vent breakdown of labeled 3’,5’-AMP. Lipocyte 
“ghosts” were prepared according to the method of 
Rodbell [ 161 , suspended in Tris buffer with 1% bovine 
albumin and assayed for adenyl cyclase activity accord- 
ing to a modification of the method of Krishna et al. 
[ 191. The incubation system contained: 20 mM 
Tris-HCI, pH 7.4,4.5 mM MgCls, 1 mM 3’,5’-AMP, 
0.45 mM 32P-ATP, 10 mM creatine phosphate, 300 pg 
creatinkinase, and hormones as indicated in a total 
vol of 0.1 ml. The reaction was started with the addi- 
tion of ghost-suspensions (So-100 /lg protein/test) 
and allowed to proceed for 10 min at 37”. Forma- 
tion of 3’,5’-AMP was strictly linear with time and 
protein concentration. Phosphodiesterase activity 
in liver and ghost preparations as measured according 
to the method of Loten and Sneyd [9] was too small 
to account for a si~i~cant breakdown of 3’,5’-AMP 
under assay conditions. 
3. Results and discussion 
Preliminary studies suggested that the antagonism 
of glucagon and insulin was competitive with respect 
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Table 1 
Inhibition of glucagon effect upon adenyl cyclase activity of mouse liver by insulin. 
Additions No. of Adenyl cyclase activity 
(nmoles X g protein-’ X min-‘) 
A P 
experiments 
None 11 8.8 + 1.9 
Glucagon, 
0.5 clg/ml 11 26.1 f 3.9 
Glucagon, 10.2 < 0.0005 0.5 pgg/ml * 2.2 
+ insulin, 
100 pU/ml 11 16.5 + 3.8 
Assay conditions as described [14]. Crystalline porcine insulin from the Novo Co. and crystalline bovine insulin from Farbwerke 
Hoechst were used. Values indicate mean f S.E.M., significance of difference was calculated on the basis of paired comparison. 
Insulm, mU/ml 0 0.05 01 5.0 100 
Fig. 1. Effect of increasing concentrations of crystalline in- 
sulin upon glucagon stimulated adenyl cyclase activity from 
mouse liver. Submaximal stimulation by 0.5 &ml of synthe- 
tic glucagon, crystalline bovine insulin from Novo, Copenhagen. 
to activation of the liver enzyme. We therefore used 
submaximal concentrations of synthetic glucagon as 
shown in table 1. The table represents 11 experiments 
with different liver preparations performed over the 
period of 10 mon. Although considerable variation 
was observed due to differences in animals and quali- 
ty of 32P-ATP used, the effect of insulin was highly 
significant on the basis of paired comparison. Fig. 1 
Table 2 
Fluoride stimulation of mouse liver adenyl cyclase in the 
presence and absence of insulin. 
Additions 
Adenyl cyclase activity 
(nmoles X g protein-’ X min-r ) 
Experiment I Experiment II 
None 
NaF, 10 mM 
NaF, 10 mM 
+ insulin, 
100 MU/ml 
3.9 4.0 
37.9 44.5 
43.6 40.0 
shows that the effect was most pronounced at low 
concentrations of insulin, which lie in the physiolo- 
gical range, and decreased again when more hormone 
was added. When the system was stimulated by 10 mM 
NaF, no effect of insulin could be observed (table 2), 
suggesting insulin action at a step between the glucagon 
receptor and the catalytic unit of the adenyl cyclase 
system which is thought to be directly stimulated by 
fluoride [20]. The experiment provides also evidence 
against the possible stimulation of 3’,5’-AMP break- 
down by insulin under assay conditions. 
Studies with lipocyte ghosts showed that the effect 
of insulin is not restricted to the liver preparation. 
The effect of submaximal concentrations of norepin- 
ephrine, glucagon and ACTH could be significantly 
reversed by 50 VU/ml of crystalline insulin, a concen- 
tration which lies well within the physiological range 
(table 3). Again, insulin had no effect upon the fluor- 
ide-stimulated system and did not inhibit the basal 
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Table 3 
Effect of crystalline insulin upon adenyl cyclase activity in lipocyte ghosts submaximally stimulate0 oy norepinephrine, glueagon, 
and ACTH. 
Additions No. of Adenyl cyclase activity 
experiments (nmoles X g protein -’ X min-‘1 
None 10 108.7 + 13.3 
Norep~ep~~e 5 X 10-‘M 10 167.5 f 21.1 
+ Insulin, 50 MU/ml 10 117.0 + 14.8 
Glucagon, 0.2 &ml 7 181.3 + 19.1 
+ Insulin, 50 JJ/ml 7 125.1 + 10.9 
ACTH, 0.03 &ml 2 297.9 
+ Insulin, 50 MU/ml 2 196.6 
The stimulation was almost compeltely reversed in the case of noreplnepbrine and glucagon. 
A P 
50.5 < 0.005 
f 7.5 
56.2 < 0.01 
f 15.8 
101.3 
Table 4 
Absence of insulin ~ibition of basal and fluoride~tim~ted 
adenyl cyclase activity in lipocyte ghosts. 
Additions Adenyl cyclase activity 
(nmoles X g protein-* X min-‘) 
Experiment I 
Basal 
+ insulin, 50 J&u/ml 
•t- insulin, 500 @U/ml 
128.4 
125.9 
157.9 
Experiment II 
NaF, 1 mM 
+ insulin, 50 ~Ulml 
NaF, 2 mM 
+ insulin, 50 r&l/ml 
NaF, 10 mM 
+ insulin, 50 rU/ml 
131.9 
131.4 
261.7 
262.2 
958.3 
917.5 
activity (table 4). In accordance with our findings on 
the liver preparation, the effect was reversed by in- 
creasing the concentration of insulin (fig. 2). This 
phenomenon may explain the earlier observations by 
Iavis et al. [2 l] who showed a paradoxical failure 
of high concentrations of insulin to block epinephrine- 
induced lipolysis in isolated fat cells. In all insulin 
preparations used glucagon contamination was far 
too low to explain these effects. 
From the present data it appears that several ex- 
perimental conditions are essential for the demonstra- 
tion of an insulin effect upon the hormone stimulated 
adenyl cyclase system: (1) the use of submaximal con- 
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Fig. 2. Antagonism of norepinephrine and insulin in activation 
of adenyl cyclase activity of fat cell gbosts. 
centrations of stimulant and low concentrations of 
insulin, (2) low concentration of substrate, (3) fresh 
membrane preparations, and (4) possibly the omission 
of methylxanthines from the assay system. Our find- 
ings suggest hat the earlier observed decrease of the 
levels of cyclic AMP in liver and adipose tissue is a 
consequence of the interaction of insulin and its anta- 
gonists at some step in the activation system of adenyl 
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cyclase. The primary event of insulin action in the 
course of its effect upon metabolic functions such as 
glycogen metabolism, gluconeogenesis, ketogenesis, 
urea production in liver and lipolysis in adipose tissue 
could thus be inhibition of the adenyl cyclase system 
in the plasma membrane. For this the hormone would 
not have to enter the cells. Although an additional 
action of insulin upon the cyclic nucleotide phospho- 
diesterase seems possible, convincing effects have 
thus far only been shown after treatment of whole 
cells with the hormone [8,9]. In this case an indi- 
rect activation could still have been caused by meta- 
bolite changes secondary to insulin action upon the 
adenyl cyclase system. 
Although there is some indication that in the 
liver preparations insulin, like NSILA-S, inhibits the 
basal as well as the hormone-stimulated cyclase acti- 
vity, it is not clear whether adhering stimulatory 
hormones may have still been active under “basal” 
conditions. In view of the longer preparative pro- 
cedure this seems less likely in the ghost preparation 
where no effect could be observed upon the basal 
activity. It is, however, evident that under most 
physiological conditions in vim, agonistic as well as 
antagonistic hormones will be present. 
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